These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Dose-effect study of intranasal administration of growth hormone-releasing hormone-44-NH2 in healthy subjects. Khalfallah Y; Navailles B; Cohen R; Laville P; Kalita C; Cabrera P; Frangin G; Sassolas G J Clin Endocrinol Metab; 1990 Aug; 71(2):512-5. PubMed ID: 2116440 [TBL] [Abstract][Full Text] [Related]
16. The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature. Borkenstein M Acta Endocrinol Suppl (Copenh); 1986; 279():135-8. PubMed ID: 2877535 [TBL] [Abstract][Full Text] [Related]
17. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. Takano K; Hizuka N; Shizume K; Asakawa K; Miyakawa M; Hirose N; Shibasaki T; Ling NC J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432 [TBL] [Abstract][Full Text] [Related]
19. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells. Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF Endocrinology; 1985 Mar; 116(3):1066-70. PubMed ID: 3918846 [TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH)-releasing factor (GRF) pretreatment enhances the GRF-induced GH secretion in rats with the pituitary autotransplanted to the kidney capsule. Jansson JO; Carlsson L; Isaksson OG Endocrinology; 1985 Jan; 116(1):95-8. PubMed ID: 3917256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]